glp 1 new GLP-1 Weight Loss Drugs May Reduce Chance of Cancer Progressing, Study Finds New Biweekly GLP-1 Shot Lowers

Based on this review, evidence from head-to-head and insulin-comparator trials demonstrates that dual GIP/GLP-1 co-agonism consistently overcomes metabolic plateaus that result from single-pathway therapy, producing superior glycated hemoglobin reduction, bariatric-level weight loss (up to 25.3%), and robust macrovascular and heart failure protection, including a 38% reduction in composite cardiovascular risk among patients with heart failure with preserved ejection fraction (HFpEF)

Obesity is a chronic condition

Inside you'll find practical, protein-focused meals, grocery lists, planners, and trackers designed specifically for people using GLP-1 medications and navigating a changing appetite

We need to have a more balanced conversation about GLP-1 medications